Explore By Subject Area   
Return Home
Register Here Menu

Mobile in Clinical Trials

Date: Sep 16, 2024

Location: Philadelphia, PA

Day: Monday, September 16, 2024
Showing Events in 1 Track from 07:45am to 09:55am
Morning General Session
7:45AM - 8:15AM
Registration
8:30AM - 8:45AM
Co-Chair’s Welcome
Co-Chairs:
Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes
Kai Bode, Principal Scientist, Preclinical Development, Merck
Adama Ibrahim, MBA, VP, Digital Strategy and Change Management, Novo Nordisk
8:45AM - 9:15AM
What Patients Really Want (or Don’t Want): Preferences and Needs for Digital Technologies in Clinical Trials
Moderator:
Lani Hashimoto, Associate Director, Patient Engagement Management, Novartis
Panelists:
Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes
Patrick Gee Sr, PhD, JLC, Patient Advocate, Founder & Chief Executive Hope Dealer, iAdvocate, Inc
Celline Mitchell, Patient, Advocate
Rucha Shah, Patient Advocate, and Assistant Clinical Research Project Manager, ECOG-ACRIN Cancer Research Group
9:15AM - 9:45AM
Site Perspectives on Navigating Adoption Hurdles with Mobile Tech to Enhance Clinical Trial Recruitment and Retention
Moderator:
Marie Emms, Head, Patient Engagement and Recruitment, BMS
Panelists:
Jillian Agnew, RN, CCRC, Clinical Research Coordinator, St Johns Center for Clinical Research
Mahasweta Dutt, MS, MRA, CCRC, Associate Director- Clinical Research Operations, Office of Clinical Research, Penn Medicine
Rucha Shah, Patient Advocate, and Assistant Clinical Research Project Manager, ECOG-ACRIN Cancer Research Group
9:45AM - 9:55AM
Open Q&A with Patients and Sites on DHTs in Clinical Trials
Led by:
Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes
Kai Bode, Principal Scientist, Preclinical Development, Merck
Adama Ibrahim, MBA, VP, Digital Strategy and Change Management, Novo Nordisk
Showing Events in 1 Track from 09:55am to 10:20am
Grand Opening Break and Networking
9:55AM - 10:20AM
Grand Opening Break and Networking
Showing Events in 1 Track from 10:20am to 12:15pm
Morning General Session Continued
10:20AM - 10:55AM
Next Generation Investment to Support Patients and Sites Remotely in Clinical Trials - Navigating the Landscape and Practical Steps for Success
Moderator:
Adama Ibrahim, MBA, VP, Digital Strategy and Change Management, Novo Nordisk
Panelists:
Kurt Lumsden, VP Study Operations, Hawthorne Health, Inc.
Amanda Moore, Vice President, Program Leadership and Clinical Operations, Abeona Therapeutics
Casey Orvin, Chief Commercial Officer, Alcanza Clinical Research, LLC
Zak Smith, Senior Data Scientist, Tufts Center for the Study of Drug Development
10:55AM - 11:35AM
Interactive Session: Working Through Key Challenges in Implementing Mobile Technology Options for Patients to Expand Access and Optimize Trial Outcomes
Led by:
Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes
Ebony Dashiell-Aje, PhD, Executive Director, Patient Centered Outcomes Science (PCOS), BioMarin Pharmaceutical Inc
11:35AM - 12:15PM
Annual Technology Showcase and Demos
Led by:
Kai Bode, Principal Scientist, Preclinical Development, Merck
Participants:
Geoff Gill, CEO, Verisense Health, Inc.
Matthew Jones, Director of Product Management, Spencer Health Solutions
Nagesh Kadaba, PhD, Founder CEO, Status Alert LLC
Anthony Mikulaschek, VP, Commercialization, IQVIA Patient Suite
Wessam Sonbol, CEO, Delve Health
Participating Companies:
Showing Events in 1 Track from 12:15pm to 01:15pm
Lunch and Networking
12:15PM - 1:15PM
Lunch and Networking
Showing Events in 2 Tracks from 01:15pm to 01:50pm
Track 1: AI Integration in Mobile Tech
Track Chair:
Lani Hashimoto, Associate Director, Patient Engagement Management, Novartis
1:15PM - 1:40PM
How can AI be Utilized in Mobile Technologies and What's Next?
Led by:
Adama Ibrahim, MBA, VP, Digital Strategy and Change Management, Novo Nordisk
1:40PM - 1:50PM
Grove AI: Accelerating Participant Recruitment & Engagement at Scale with AI
Speakers:
Sohit Gatiganti, CPO and Co-Founder of Grove, Grove AI
Trân Lê, CEO and Co-Founder, Grove AI
Track 2: New Novel Endpoints & Digital Biomarkers Panel
Track Chair:
Dan Eversole, PhD, Associate Director, Digital Strategy, Takeda
1:15PM - 1:50PM
Panel: Adopting New Novel Endpoints and Digital Biomarkers via Wearable Devices
Moderator:
Stephen Ruhmel, MPH, Clinical Strategy Lead for Digital Endpoints, Sanofi
Panelists:
Nishit Agarwal, Senior Data Science Engineer, Medidata
Bharat Koyani, Associate Director, Digital Biomarker, Regeneron
Katerina Placek, PhD, Senior Manager, Digital Health Sciences, Takeda
Rob Wilson, Vice President Commercial Strategy, VivoSense
Hao Zhang, PhD, MBA, Director, Digital Healthcare Innovation, Mitsubishi Tanabe Pharma America
Showing Events in 1 Track from 01:50pm to 03:10pm
Afternoon Track Choices
1:50PM - 3:10PM
Two Track Choices: Case Studies Demonstrating the Impact of Mobile Technologies on Patient Support in Clinical Trials
Participating Companies:
Showing Events in 2 Tracks from 01:50pm to 03:10pm
Track 1: Patient Engagement, Patient-Centric Digital Trial Advancements, Linguistic Design & Accessibility
Track Chair:
Lani Hashimoto, Associate Director, Patient Engagement Management, Novartis
1:50PM - 2:10PM
Moderna: The Impact of Mobile/Digital Tech in Pediatric Trials
Speaker:
Mackenzie McKinney, Sr. Manager, Patient Centricity, Moderna
2:10PM - 2:30PM
RWS & Kayentis: Innovations in Language and Design for Accelerating eCOA Implementation
Speakers:
Elliott Labouré, Senior COA Partnership Manager, RWS Group
Andrea Murison, Senior Director, Business Development, Kayentis
2:30PM - 2:50PM
Chiesi Farmaceutici: Patient and Provider Insights from Decentralized Trials to Help Shape the Future of Patient-Centric Research
Speaker:
Eva Topole, MD, Clinical Digital Health and Innovation Lead, Chiesi Farmaceutici S.p.A
2:50PM - 3:10PM
Merck: Advancing Clinical Trials Through Digital Accessibility - Strategies for Inclusive Design
Speaker:
Stephen Framil, DMA, Corporate Global Head of Accessibility, Merck
Track 2: Diversity & Inclusion, DHT Validation, Scaling Mobile and Digital Tech
Track Chair:
Dan Eversole, PhD, Associate Director, Digital Strategy, Takeda
1:50PM - 2:10PM
AstraZeneca: New Thinking in Reaching More Communities Remotely
Speakers:
Eileen Babcock, PA-C, MBA, Senior Director of Clinical Operations, AstraZeneca
Maria Jison, MD, Global Clinical Head, AstraZeneca
2:10PM - 2:30PM
Takeda: Validating Digital Health Tools to Advance Pediatric Decentralized Trials
Speaker:
Katerina Placek, PhD, Senior Manager, Digital Health Sciences, Takeda
2:30PM - 2:50PM
Clemson Rural Health: Scaling Mobile Health Units for Clinical Trials - Bridging Healthcare Gaps
Speakers:
Kristie Boswell, DNP, APRN, FNP-C, Assistant Director, Mobile Operations, Clemson Rural Health, Clemson University
Jeremy Shields, Clinical Research Associate, Clemson Rural Health, Clemson University
2:50PM - 3:10PM
Pfizer: Mobile Technology Integration in Clinical Trials to Enhance Patient Experience and Study Outcomes
Speaker:
Christopher Dell, MBA, Senior Manager of Patient Solutions, Pfizer
Showing Events in 1 Track from 03:10pm to 03:35pm
Afternoon Break and Networking
3:10PM - 3:35PM
Afternoon Break and Networking
Showing Events in 1 Track from 03:35pm to 05:25pm
Afternoon General Session
3:35PM - 4:15PM
Demonstrating the Value and ROI of Digital Technologies in Trials
Moderator:
Zak Smith, Senior Data Scientist, Tufts Center for the Study of Drug Development
Panelists:
Jakob Alme, Director, Digital Innovation, Sage Therapeutics
Greg Christie, Chief Product Officer, StudyKIK, a Syneos Health Company
Christina Fawcett, Director of Digital Health Delivery, GSK
Alex Simmonds, MBA, Drug Development Innovation Lead, BMS
Edward Triebell, MBA, Commercial Executive Director, MRN Technologies
4:15PM - 5:00PM
Addressing Globalization Challenges in Digital Health Technologies (DHTs) Implementation
Moderator:
Hao Zhang, PhD, MBA, Director, Digital Healthcare Innovation, Mitsubishi Tanabe Pharma America
Panelists:
Afia Afzal, Sr Director, Applied Innovation and Portfolio Management, R&D Data Science, Global Development, Johnson & Johnson
Sandeep Bhat, Digital Engagement Lead, Global Clinical Operations, GSK
Erica Lively, Ph.D., P.E., Practice Director, Principal Engineer, Exponent
Madelaine MacKay, Sr Director, eClinical Development & Delivery, ICON plc
5:00PM - 5:25PM
Enhancing Patient Access in Clinical Trials: FDA Updates on Decentralization and Digital Health Technologies
Speaker:
Leonard Sacks, MD, Acting Deputy Director, Office of Medical Policy, CDER, FDA
Showing Events in 1 Track from 05:25pm to 05:30pm
End of Conference
5:25PM - 5:30PM
End of Conference
Showing Events in 1 Track from 07:45am to 09:55am
Morning General Session
7:45AM - 8:15AM
Registration
8:30AM - 8:45AM
Co-Chair’s Welcome
Co-Chairs:
Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes
Kai Bode, Principal Scientist, Preclinical Development, Merck
Adama Ibrahim, MBA, VP, Digital Strategy and Change Management, Novo Nordisk
8:45AM - 9:15AM
What Patients Really Want (or Don’t Want): Preferences and Needs for Digital Technologies in Clinical Trials
Moderator:
Lani Hashimoto, Associate Director, Patient Engagement Management, Novartis
Panelists:
Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes
Patrick Gee Sr, PhD, JLC, Patient Advocate, Founder & Chief Executive Hope Dealer, iAdvocate, Inc
Celline Mitchell, Patient, Advocate
Rucha Shah, Patient Advocate, and Assistant Clinical Research Project Manager, ECOG-ACRIN Cancer Research Group
9:15AM - 9:45AM
Site Perspectives on Navigating Adoption Hurdles with Mobile Tech to Enhance Clinical Trial Recruitment and Retention
Moderator:
Marie Emms, Head, Patient Engagement and Recruitment, BMS
Panelists:
Jillian Agnew, RN, CCRC, Clinical Research Coordinator, St Johns Center for Clinical Research
Mahasweta Dutt, MS, MRA, CCRC, Associate Director- Clinical Research Operations, Office of Clinical Research, Penn Medicine
Rucha Shah, Patient Advocate, and Assistant Clinical Research Project Manager, ECOG-ACRIN Cancer Research Group
9:45AM - 9:55AM
Open Q&A with Patients and Sites on DHTs in Clinical Trials
Led by:
Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes
Kai Bode, Principal Scientist, Preclinical Development, Merck
Adama Ibrahim, MBA, VP, Digital Strategy and Change Management, Novo Nordisk
Showing Events in 1 Track from 09:55am to 10:20am
Grand Opening Break and Networking
9:55AM - 10:20AM
Grand Opening Break and Networking
Showing Events in 1 Track from 10:20am to 12:15pm
Morning General Session Continued
10:20AM - 10:55AM
Next Generation Investment to Support Patients and Sites Remotely in Clinical Trials - Navigating the Landscape and Practical Steps for Success
Moderator:
Adama Ibrahim, MBA, VP, Digital Strategy and Change Management, Novo Nordisk
Panelists:
Kurt Lumsden, VP Study Operations, Hawthorne Health, Inc.
Amanda Moore, Vice President, Program Leadership and Clinical Operations, Abeona Therapeutics
Casey Orvin, Chief Commercial Officer, Alcanza Clinical Research, LLC
Zak Smith, Senior Data Scientist, Tufts Center for the Study of Drug Development
10:55AM - 11:35AM
Interactive Session: Working Through Key Challenges in Implementing Mobile Technology Options for Patients to Expand Access and Optimize Trial Outcomes
Led by:
Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes
Ebony Dashiell-Aje, PhD, Executive Director, Patient Centered Outcomes Science (PCOS), BioMarin Pharmaceutical Inc
11:35AM - 12:15PM
Annual Technology Showcase and Demos
Led by:
Kai Bode, Principal Scientist, Preclinical Development, Merck
Participants:
Geoff Gill, CEO, Verisense Health, Inc.
Matthew Jones, Director of Product Management, Spencer Health Solutions
Nagesh Kadaba, PhD, Founder CEO, Status Alert LLC
Anthony Mikulaschek, VP, Commercialization, IQVIA Patient Suite
Wessam Sonbol, CEO, Delve Health
Participating Companies:
Showing Events in 1 Track from 12:15pm to 01:15pm
Lunch and Networking
12:15PM - 1:15PM
Lunch and Networking
Showing Events in 2 Tracks from 01:15pm to 01:50pm
Track 1: AI Integration in Mobile Tech
Track Chair:
Lani Hashimoto, Associate Director, Patient Engagement Management, Novartis
1:15PM - 1:40PM
How can AI be Utilized in Mobile Technologies and What's Next?
Led by:
Adama Ibrahim, MBA, VP, Digital Strategy and Change Management, Novo Nordisk
1:40PM - 1:50PM
Grove AI: Accelerating Participant Recruitment & Engagement at Scale with AI
Speakers:
Sohit Gatiganti, CPO and Co-Founder of Grove, Grove AI
Trân Lê, CEO and Co-Founder, Grove AI
Track 2: New Novel Endpoints & Digital Biomarkers Panel
Track Chair:
Dan Eversole, PhD, Associate Director, Digital Strategy, Takeda
1:15PM - 1:50PM
Panel: Adopting New Novel Endpoints and Digital Biomarkers via Wearable Devices
Moderator:
Stephen Ruhmel, MPH, Clinical Strategy Lead for Digital Endpoints, Sanofi
Panelists:
Nishit Agarwal, Senior Data Science Engineer, Medidata
Bharat Koyani, Associate Director, Digital Biomarker, Regeneron
Katerina Placek, PhD, Senior Manager, Digital Health Sciences, Takeda
Rob Wilson, Vice President Commercial Strategy, VivoSense
Hao Zhang, PhD, MBA, Director, Digital Healthcare Innovation, Mitsubishi Tanabe Pharma America
Showing Events in 1 Track from 01:50pm to 03:10pm
Afternoon Track Choices
1:50PM - 3:10PM
Two Track Choices: Case Studies Demonstrating the Impact of Mobile Technologies on Patient Support in Clinical Trials
Participating Companies:
Showing Events in 2 Tracks from 01:50pm to 03:10pm
Track 1: Patient Engagement, Patient-Centric Digital Trial Advancements, Linguistic Design & Accessibility
Track Chair:
Lani Hashimoto, Associate Director, Patient Engagement Management, Novartis
1:50PM - 2:10PM
Moderna: The Impact of Mobile/Digital Tech in Pediatric Trials
Speaker:
Mackenzie McKinney, Sr. Manager, Patient Centricity, Moderna
2:10PM - 2:30PM
RWS & Kayentis: Innovations in Language and Design for Accelerating eCOA Implementation
Speakers:
Elliott Labouré, Senior COA Partnership Manager, RWS Group
Andrea Murison, Senior Director, Business Development, Kayentis
2:30PM - 2:50PM
Chiesi Farmaceutici: Patient and Provider Insights from Decentralized Trials to Help Shape the Future of Patient-Centric Research
Speaker:
Eva Topole, MD, Clinical Digital Health and Innovation Lead, Chiesi Farmaceutici S.p.A
2:50PM - 3:10PM
Merck: Advancing Clinical Trials Through Digital Accessibility - Strategies for Inclusive Design
Speaker:
Stephen Framil, DMA, Corporate Global Head of Accessibility, Merck
Track 2: Diversity & Inclusion, DHT Validation, Scaling Mobile and Digital Tech
Track Chair:
Dan Eversole, PhD, Associate Director, Digital Strategy, Takeda
1:50PM - 2:10PM
AstraZeneca: New Thinking in Reaching More Communities Remotely
Speakers:
Eileen Babcock, PA-C, MBA, Senior Director of Clinical Operations, AstraZeneca
Maria Jison, MD, Global Clinical Head, AstraZeneca
2:10PM - 2:30PM
Takeda: Validating Digital Health Tools to Advance Pediatric Decentralized Trials
Speaker:
Katerina Placek, PhD, Senior Manager, Digital Health Sciences, Takeda
2:30PM - 2:50PM
Clemson Rural Health: Scaling Mobile Health Units for Clinical Trials - Bridging Healthcare Gaps
Speakers:
Kristie Boswell, DNP, APRN, FNP-C, Assistant Director, Mobile Operations, Clemson Rural Health, Clemson University
Jeremy Shields, Clinical Research Associate, Clemson Rural Health, Clemson University
2:50PM - 3:10PM
Pfizer: Mobile Technology Integration in Clinical Trials to Enhance Patient Experience and Study Outcomes
Speaker:
Christopher Dell, MBA, Senior Manager of Patient Solutions, Pfizer
Showing Events in 1 Track from 03:10pm to 03:35pm
Afternoon Break and Networking
3:10PM - 3:35PM
Afternoon Break and Networking
Showing Events in 1 Track from 03:35pm to 05:25pm
Afternoon General Session
3:35PM - 4:15PM
Demonstrating the Value and ROI of Digital Technologies in Trials
Moderator:
Zak Smith, Senior Data Scientist, Tufts Center for the Study of Drug Development
Panelists:
Jakob Alme, Director, Digital Innovation, Sage Therapeutics
Greg Christie, Chief Product Officer, StudyKIK, a Syneos Health Company
Christina Fawcett, Director of Digital Health Delivery, GSK
Alex Simmonds, MBA, Drug Development Innovation Lead, BMS
Edward Triebell, MBA, Commercial Executive Director, MRN Technologies
4:15PM - 5:00PM
Addressing Globalization Challenges in Digital Health Technologies (DHTs) Implementation
Moderator:
Hao Zhang, PhD, MBA, Director, Digital Healthcare Innovation, Mitsubishi Tanabe Pharma America
Panelists:
Afia Afzal, Sr Director, Applied Innovation and Portfolio Management, R&D Data Science, Global Development, Johnson & Johnson
Sandeep Bhat, Digital Engagement Lead, Global Clinical Operations, GSK
Erica Lively, Ph.D., P.E., Practice Director, Principal Engineer, Exponent
Madelaine MacKay, Sr Director, eClinical Development & Delivery, ICON plc
5:00PM - 5:25PM
Enhancing Patient Access in Clinical Trials: FDA Updates on Decentralization and Digital Health Technologies
Speaker:
Leonard Sacks, MD, Acting Deputy Director, Office of Medical Policy, CDER, FDA
Showing Events in 1 Track from 05:25pm to 05:30pm
End of Conference
5:25PM - 5:30PM
End of Conference

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.